Department of Hypertension and Plateau Disease, Qinghai Province Cardiovascular and Cerebrovascular Disease Specialist Hospital, Qinghai, China.
College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
Front Endocrinol (Lausanne). 2023 Mar 8;14:1145914. doi: 10.3389/fendo.2023.1145914. eCollection 2023.
Estimated pulse wave velocity (ePWV) has been proposed as a potential alternative to carotid-femoral pulse wave velocity to assess the degree of aortic stiffness, and may predict cardiovascular disease (CVD) outcomes and mortality in the general population. However, whether arterial stiffness estimated by ePWV predicts all-cause and cause-specific mortality in patients with diabetes mellitus (DM) has not been reported.
This was a prospective cohort study with data from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2014 and followed up until the end of December 2019. 5,235U.S. adults with DM (age≥20years) were included in the study. Arterial stiffness was estimated by ePWV. Survey-weighted Cox proportional hazards models were performed to assess the hazard ratios (HRs), and 95% confidence intervals (CIs) for the associations of ePWV with all-cause and cause-specific mortality. Meanwhile, the generalized additive model was used to visually assess the dose-dependent relationship between ePWV and mortality. As a complementary analysis, the relationship between mean blood pressure (MBP) and risk of mortality was also examined. Multiple imputations accounted for missing data.
For the 5,235 DM patients, the weighted mean age was 57.4 years, and 51.07% were male. During a median follow-up period of 115 months (interquartile range 81-155 months; 53,159 person-years), 1,604 all-cause deaths were recorded. In the fully adjusted Cox regression model, every 1 m/s increase in ePWV was associated with 56% (HR 1.56; 95% CI, 1.44 to 1.69) increase in the risk of all-cause. In addition, a nonlinear relationship between ePWV and all-cause mortality was observed (P for non-linear=0.033). Similar results were obtained after subgroup analysis and multiple imputations. Besides, the risk of most cause-specific mortality, except for accident and renal disease-specific mortality, increased from 53% to 102% for every 1 m/s increase in ePWV.
In the diabetic population, ePWV is independently associated with all-cause and most cause-specific mortality risks. ePWV may be a useful tool for assessing mortality risk.
估算脉搏波速度(ePWV)已被提出作为评估主动脉僵硬度的颈动脉-股动脉脉搏波速度的替代方法,并且可能预测普通人群的心血管疾病(CVD)结局和死亡率。然而,ePWV 估计的动脉僵硬度是否可预测糖尿病患者的全因和特定原因死亡率尚未报道。
这是一项前瞻性队列研究,数据来自 1999 年至 2014 年的全国健康和营养检查调查(NHANES),随访至 2019 年 12 月底。研究纳入了 5235 名年龄≥20 岁的美国糖尿病患者。通过 ePWV 估算动脉僵硬度。采用调查加权 Cox 比例风险模型评估 ePWV 与全因和特定原因死亡率的风险比(HR)和 95%置信区间(CI)。同时,使用广义加性模型直观评估 ePWV 与死亡率之间的剂量-反应关系。作为补充分析,还检查了平均血压(MBP)与死亡率风险之间的关系。多重插补用于处理缺失数据。
在 5235 名糖尿病患者中,加权平均年龄为 57.4 岁,51.07%为男性。在中位随访期 115 个月(四分位距 81-155 个月;53159 人年)期间,记录了 1604 例全因死亡。在完全调整的 Cox 回归模型中,ePWV 每增加 1m/s,全因死亡风险增加 56%(HR 1.56;95%CI,1.44 至 1.69)。此外,还观察到 ePWV 与全因死亡率之间存在非线性关系(P 非线性=0.033)。在亚组分析和多重插补后也得到了类似的结果。此外,ePWV 每增加 1m/s,除意外和肾脏疾病特异性死亡率外,大多数特定原因死亡率的风险增加 53%至 102%。
在糖尿病患者中,ePWV 与全因和大多数特定原因死亡率风险独立相关。ePWV 可能是评估死亡率风险的有用工具。